Certificate of Achievement
has completed the following course:
Optimise Aminoglycoside Use in Clinical Practice
On this course, you have explored how aminoglycosides work and the types of clinical conditions in which they should be used. You have learnt how they should be dosed, and should be able to detail how they can be used in special patient groups.
This course has been approved by the Royal College of Pathologists at a level of 9 Points.
3 weeks, 3 hours per week
Naomi Fleming
Antimicrobial Pharmacist
BSAC
Transcript
Learning outcomes
- Demonstrate an understanding of how aminoglycosides work, what bacteria they are effective against and their mechanism of action
- Identify the clinical conditions in which these antimicrobials are used and their risks/side effects
- Describe how genetic testing can be used to identify patients at increased risk of developing side effects
- Explain key PK and PD parameters and how they are related to aminoglycoside action and efficacy
- Summarise how aminoglycoside dosing is calculated using the Cockcroft-Gault equation and appreciate the different patient groups where dosing calculations may differ
- Describe the importance of TDM when administering aminoglycosides and associated challenges when interpreting results
- Describe the effects of renal impairment, age, weight, pregnancy and other important clinical scenarios on aminoglycoside dosing and use
- Summarise the key ways microorganisms become resistant to aminoglycosides and explain the clinical implications of such resistance
Syllabus
- How aminoglycosides work, what bacteria they are effective against and their mechanism of action
- The clinical conditions for which these antimicrobials are used
- Risks and side effects
- The use of genetic testing to identify patients at increased risk of developing side effects
- Important pharmacokinetic (PK) and pharmacodynamic (PD) parameters related to aminoglycoside action and efficacy
- Dosing and therapeutic drug monitoring of aminoglycosides
- Use of aminoglycosides in special patient groups
- Resistance to aminoglycosides
In association with
Issued on 17th March 2026
The person named on this certificate has completed the activities in the transcript above. For more information about Certificates of Achievement and the effort required to become eligible, visit futurelearn.com/proof-of-learning/certificate-of-achievement.
This certificate represents proof of learning. It is not a formal qualification, degree, or part of a degree.